His scientific interests lie mostly in Biochemistry, Mycobacterium tuberculosis, Microbiology, Mycobacterium smegmatis and Enzyme. Dean C. Crick studied Biochemistry and Lipoarabinomannan that intersect with ATP synthase. His biological study spans a wide range of topics, including Glycosylation, Mode of action and Membrane transport protein.
His research integrates issues of Mycobacterium and Bacteria in his study of Microbiology. His work in Mycobacterium smegmatis addresses issues such as Mutant, which are connected to fields such as Transmembrane domain. His Enzyme research incorporates themes from In vitro toxicology and Escherichia coli.
Dean C. Crick mostly deals with Biochemistry, Mycobacterium tuberculosis, Microbiology, Biosynthesis and Mycobacterium smegmatis. His research is interdisciplinary, bridging the disciplines of Lipoarabinomannan and Biochemistry. Dean C. Crick works mostly in the field of Mycobacterium tuberculosis, limiting it down to topics relating to ATP synthase and, in certain cases, Erythritol.
His work carried out in the field of Microbiology brings together such families of science as Drug target and Bacteria. As a part of the same scientific study, Dean C. Crick usually deals with the Biosynthesis, concentrating on Prenylation and frequently concerns with Farnesyl pyrophosphate and Geranylgeraniol. His study looks at the intersection of Mycobacterium smegmatis and topics like Mycobacterium with Galactan.
Dean C. Crick spends much of his time researching Mycobacterium tuberculosis, Nuclear magnetic resonance spectroscopy, Membrane, Growth inhibition and Microbiology. His Mycobacterium tuberculosis research integrates issues from In vitro, Biosynthesis, Enzyme, Natural product and Pharmacology. His Membrane research also works with subjects such as
The various areas that Dean C. Crick examines in his Growth inhibition study include Pyrazinamide, Acid–base reaction, Mycobacterium smegmatis, Vanadium and Vanadate. His Mycobacterium smegmatis study combines topics in areas such as Medicinal chemistry, Growth medium, Hydrolysis, Aqueous solution and Monomer. His research in Microbiology focuses on subjects like Gene, which are connected to Bacteria.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis
Dean C. Crick;Sebabrata Mahapatra;Patrick J. Brennan.
Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways.
Brian C. VanderVen;Jeffery D. Harder;Dean C. Crick;John T. Belisle.
Phosphatidylinositol Is an Essential Phospholipid of Mycobacteria
Mary Jackson;Dean C. Crick;Patrick J. Brennan.
Journal of Biological Chemistry (2000)
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
Kai Li;Lici A. Schurig-Briccio;Xinxin Feng;Ashutosh Upadhyay.
Journal of Medicinal Chemistry (2014)
Decaprenylphosphoryl Arabinofuranose, the Donor of the D-Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose
Katarína Mikušová;Hairong Huang;Tetsuya Yagi;Marcelle Holsters.
Journal of Bacteriology (2005)
The Cell-Wall Core of Mycobacterium tuberculosis in the Context of Drug Discovery.
Patrick J Brennan;Dean C Crick.
Current Topics in Medicinal Chemistry (2007)
Identification of the namH Gene, Encoding the Hydroxylase Responsible for the N-Glycolylation of the Mycobacterial Peptidoglycan
Jon B. Raymond;Sebabrata Mahapatra;Dean C. Crick;Martin S. Pavelka.
Journal of Biological Chemistry (2005)
Unique Mechanism of Action of the Thiourea Drug Isoxyl on Mycobacterium tuberculosis
Benjawan Phetsuksiri;Mary Jackson;Hataichanok Scherman;Michael R. McNeil.
Journal of Biological Chemistry (2003)
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
Wei Li;Ashutosh Upadhyay;Fabio L. Fontes;E. Jeffrey North.
Antimicrobial Agents and Chemotherapy (2014)
Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation.
Dean C. Crick;Douglas A. Andres;Charles J. Waechter.
Biochemical and Biophysical Research Communications (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: